Researchers Bart van der Worp

Bart van der Worp

Full Professor

Strategic program(s):

Biography

Bart van der Worp is a neurologist with a special interest in cerebrovascular diseases at the University Medical Center in Utrecht, the Netherlands. He has been (co-)Chief Investigator of the randomised stroke trials HAMLET, PAIS, COOLIST, VAST, APACHE-AF, and MR ASAP and is Chief Investigator of PRECIOUS. He is a member of the Dutch CONTRAST consortium which aims to identify and test new treatments for patients with acute ischaemic stroke or intracerebral haemorrhage. He is former President of the European Stroke Organisation.

Strategic program(s):

Contact

hworp@umcutrecht.nl

Pure profile

Research groups

Intracranial vasculopathies

Research aim

Our research focusses on the diagnosis, treatment, and prevention of stroke and intracranial vasculopathies, including cerebral small vessel disease and intracranial aneurysms, with the ultimate goal to improve treatment strategies and prognosis.

Go to group

Recent publications

All publications

Deep learning-based automated segmentation of intracerebral haemorrhage, intraventricular haemorrhage and perihaematomal oedema on non-contrast CT Floor N.H. Wilting, Jules P.J. Douwes, Ajay Patel, Floris H.B.M. Schreuder, Ruben Dammers, Gerjon Hannink, Wilmar M.T. Jolink, Sjoert A.H. Pegge, Lotte Sondag, Marieke J.H. Wermer, H. Bart van der Worp, Frederick J.A. Meijer, Catharina J.M. Klijn
European Stroke Journal, 2026, vol. 11

The effects of prophylactic use of paracetamol on body temperature and blood pressure in elderly patients with acute stroke Jeroen C. de Jonge, Wouter M. Sluis, Hendrik Reinink, Philip Bath, Lisa J. Woodhouse, Diederik van de Beek, Anne Hege Aamodt, Alfonso Ciccone, Janika Kõrv, Iwona Kurkowska-Jastrzebska, Milani Deb-Chatterji, Jesse Dawson, George Ntaios, Götz Thomalla, H. Bart van der Worp,
PLoS ONE, 2026, vol. 21

Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention Mukul Sharma, Qiang Dong, Teruyuki Hirano, Scott E Kasner, Jeffrey Saver, Jaime Masjuan, Andrew M Demchuk, Charlotte Cordonnier, Daniel Bereczki, Georgios Tsivgoulis, Roland Veltkamp, Ivan Staikov, Hee-Joon Bae, Bruce C V Campbell, Andrea Zini, I-Hui Lee, Sebastian Ameriso, Martin Kovar, Robert Mikulik, Robin Lemmens, José M Ferro, Thompson Robinson, Hanne Christensen, Serefnur Ozturk, Ronen R Leker, Peter Turcani, Agnieszka Slowik, Pablo Amaya, Fan Kee Hoo, Gian Marco De Marchis, Michael Knoflach, Pillai N Sylaja, Jukka Putaala, Jonathan M Coutinho, H Bart van der Worp, Evija Miglane, Vaidas Matijosaitis, Arne G Lindgren, Gisele Sampaio Silva, Else Charlotte Sandset, Saule Tleubergenovna Turuspekova, Raed A Joundi, Karleen Schulze, Olga Shestakovska, Jennifer Gilbride, Shrikant I Bangdiwala, Lizhen Xu, Eva Muehlhofer, Pablo Colorado, Hardi Mundl,
European Stroke Journal, 2026, vol. 11

Serum biomarkers of postanoxic encephalopathy in relation to ghrelin treatment. A secondary analysis of the GRECO trial Q P M Omes, S Nutma, A Beishuizen, P M G Filius, H B van der Worp, N A Foudraine, J G Krabbe, I A Strate, M J A M van Putten, J Hofmeijer,
Resuscitation, 2026, vol. 220

MR GENTLE-multicentre randomised controlled trial of ghrelin in anterior circulation ischaemic stroke treated with endovascular thrombectomy Quinty P M Omes, Daphne van der Veen, Clemens J B A Kersten, Renate M Arntz, P Margreet G Filius, Ido R van den Wijngaard, H Bart van der Worp, Jeannette Hofmeijer
Trials, 2026, vol. 27

Cost-Effectiveness of Metoclopramide, Paracetamol, and Ceftriaxone for the Prevention of Infections and Fever in Elderly Patients with Acute Stroke Mathyn Vervaart, Jeroen C de Jonge, Philip M Bath, Hans Olav Melberg, Hendrik Reinink, Wouter M Sluis, Lisa J Woodhouse, H Bart van der Worp, Anne Hege Aamodt,
MDM policy & practice, 2026, vol. 11

External positions

national coordinator of an international trial - national coordination of this trial - Bayer

consultant - giving advice - TargED